Profile
Brian C.
Varnum served as the Chief Executive Officer & Director at Armata Pharmaceuticals, Inc. from 2021 to 2023.
Prior to that, he was the Chief Development Officer at C3 Jian LLC from 2014 to 2019.
He also held the position of Vice President-Product Development at C3J Therapeutics, Inc. from 2012 to 2014.
Dr. Varnum obtained a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the University of California.
Former positions of Brian Varnum
| Companies | Position | End |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Chief Executive Officer | 10/07/2023 |
C3 Jian LLC
C3 Jian LLC BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections | Corporate Officer/Principal | 30/04/2019 |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Corporate Officer/Principal | - |
Training of Brian Varnum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
C3 Jian LLC
C3 Jian LLC BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
- Stock Market
- Insiders
- Brian Varnum
















